Last updated:
Author(s):
Eilidh Fenner, Peter Holmans, Michael C. O'Donovan, Michael J. Owen, James T. R. Walters, Elliott Rees
Publish date:
10 April 2026
Journal:
Molecular Psychiatry
PubMed ID:
41963674

Abstract

Cognitive impairments in schizophrenia are associated with poor outcomes and are largely unimproved by current medications. It remains uncertain to what extent cognitive impairments arise from shared aetiology and biology with schizophrenia, or are a consequence of having the condition. We analysed exome-sequencing data from 76,783 UK Biobank participants without schizophrenia to test for association between generalised cognition (g) and rare (minor allele count ≤ 5) variants in schizophrenia-associated genes. Protein-truncating and deleterious missense variants in loss-of-function intolerant genes were associated with lower g. Significantly stronger effects on g were found for protein-truncating variants in genes implicated in schizophrenia by rare coding variation, and for deleterious missense variants in credible causal genes at schizophrenia common allele loci. These findings indicate that biological processes disrupted in schizophrenia by common and rare variants are associated with g in unaffected individuals, suggesting the relationship between impaired cognition and schizophrenia reflects, in part, a shared underlying biology.

Related projects

Neuropsychiatric disorders often have a profound impact on individuals, their families and wider society. Four of the six leading causes of years lived with disability…

Institution:
Cardiff University, Great Britain

All projects